Cargando…
CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma
BACKGROUND: Cell division cycle 6 (CDC6) is a key licensing factor in the assembly of pre-replicative complexes at origins of replication. The role of CDC6 in the pathogenesis of in diffuse larger B-cell lymphoma (DLBCL) remains unknown. We aim to investigate the effects of CDC6 on the proliferation...
Autores principales: | Shen, Mingfang, Zhang, Yunfeng, Tang, Lun, Fu, Qinyan, Zhang, Jiawei, Xu, Yang, Zeng, Hui, Li, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571299/ https://www.ncbi.nlm.nih.gov/pubmed/37833632 http://dx.doi.org/10.1186/s12885-023-11186-6 |
Ejemplares similares
-
Spatio-temporal regulation of the human licensing factor Cdc6 in replication and mitosis
por: Kalfalah, Faiza M, et al.
Publicado: (2015) -
Cdc6 licenses tumor growth
por: Leslie, Mitch
Publicado: (2011) -
CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
por: Wu, Wen-jing, et al.
Publicado: (2013) -
CUL4B promotes replication licensing by up-regulating the CDK2–CDC6 cascade
por: Zou, Yongxin, et al.
Publicado: (2013) -
DNA replication licensing factor Cdc6 and Plk4 kinase antagonistically regulate centrosome duplication via Sas-6
por: Xu, Xiaowei, et al.
Publicado: (2017)